Gomollón F, et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management. J Crohns Colitis. 2017 Jan;11(1):3-25
Magro F, et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017 June, 11, 6(1):649–670
Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424–1429.
Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12(4):205–217.
Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. J Am Med Assoc. 1932;99:1323 –1329.
Mulder DJ, Noble AJ, Justinich CJ, et al. A tale of two diseases: the history of inflammatory bowel disease. J Crohns Colitis. 2014;8:341-348.
Adams EW. Founders of modern medicine: Giovanni Battista Morgagni (1682–1771). Med Libr Hist J. 1903;1:270–277.
www.amiciitalia.eu
Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205–217.
Halme L, Paavola-Sakki P, Turunen U, et al. Family and twin studies in inflammatory bowel disease. World J Gastroenterol. 2006;12:3668.
Vermeire S. NOD2/CARD15: relevance in clinical practice. Best Pract Res Clin Gastroenterol. 2004;18:569–575.
Mahid SS, Minor KS, Soto RE, et al. Smoking and Inflammatory Bowel Disease: a Meta-analysis. Mayo Clin Proc. 2006;81:1462–1471.
Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146:1489–1499.
Munkholm P, Langholz E, Davidsen M, et al. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol. 1995;30:699–706.
Gajendran M, Loganathan P, Catinella AP, et al. A comprehensive review and update on Crohn's disease. Dis Mon. 2017 Aug 18. [Epub ahead of print]
Magro F, Gionchetti P, Eliakim R, et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017;11:649-670.
Lönnfors S, Vermeire S, Greco M, et al. IBD and health-related quality of life: discovering the true impact. J Crohns Colitis. 2014;8:1281-1286.
Kim YS, Jung SA, Lee KM, et al. Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases. Intest Res. 2017;15:338-344.
Cross RK Jr. Telemanagement for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2014;10:255–257.
Redmond C, Cowin C, Parker T. The experience of faecal leakage among ileostomists. Br J Nurs. 2009;18:S12–17.
Sier MF, Oostenbroek RJ, Dijkgraaf MGW, et al. Home visits as part of a new care pathway (iAID) to improve quality of care and quality of life in ostomy patients: a cluster-randomized stepped-wedge trial. Colorectal Dis. 2017;19:739-749.
Colombara F, Martinato M, Girardin G, et al. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:615–622.
Glozman JM, Bicheva KG, Fedorova NV. Scale of Quality of Life of Care-Givers (SQLC). J Neurol. 1998;245 Suppl 1:S39-S41.
Lim JW, Zebrack B. Caring for family members with chronic physical illness: A critical review of caregiver literature. Health Qual Life Outcomes. 2004;2:50.
Episodic Disability Network. Brief from the Episodic Disability Network. 2011. Available at: www.parl.gc.ca/Content/HOC/Committee/411/FINA/WebDoc/WD5138047/41.... Accessed July 10, 2015
Israeli E, Graff LA, Clara I, et al. Low prevalence of disability among patients with inflammatory bowel diseases a decade after diagnosis. Clin Gastroenterol Hepatol. 2014;12:1330–1337.e2.
Restall GJ, Simms AM, Walker JR, et al. Understanding Work Experiences of People with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:1688-1697.
Henderson P, Hansen R, Cameron FL, et al. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis. 2012;18:999–1005.
Jostins L, Ripke S, Weersma RK, et al.; International IBD Genetics Consortium [IIBDGC]. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–124.
Lee D, Albenberg L, Compher C, et al. Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology. 2015;148:1087–1106.
Tilg H, Moschen AR. Food, immunity, and the microbiome. Gastroenterology. 2015;148:1107–1119.
Hart AR, Luben R, Olsen A, et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion. 2008;77:57–64.
Sigall-Boneh R, Levine A, Lomer M, et al. Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group [Dietitians of ECCO]. J Crohns Colitis. 2017;11:1407-1419.
Gerasimidis K, McGrogan P, Edwards CA. The aetiology and impact of malnutrition in paediatric inflammatory bowel disease. J Hum Nutr Diet 2011;24:313–26.
Brasil Lopes M, Rocha R, Castro Lyra A, et al. Restriction of dairy products; a reality in inflammatory bowel disease patients. Nutr Hosp. 2014;29:575–581.
Verspreet J, Damen B, Broekaert WF, et al. A critical look at prebiotics within the dietary fiber concept. Annu Rev Food Sci Technol. 2016;7:annurev-food-081315-032749.
Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis. 1989;11:954–963.
Rahier JF, Ben-Horin S, Chowers Y, et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2009;3:47–91.
Roukens AH, Visser LG. Yellow fever vaccine: past, present and future. Expert Opin Biol Ther. 2008;8:1787–1795.
Centre for Evidence Based Medicine, Oxford. Levels of evidence and grades of recommendation. Available at: www.cebm.net/index.aspx?o¼1025. Accessed August 31, 2011.
Davis SC, Robinson BL, Vess J, et al. Primary care management of ulcerative colitis. Nurse Pract. 2017 Dec 4. [Epub ahead of print]
Kornbluth A, Sachar DB. Practice parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501–523.
Lim ML, Wallace MR. Infectious diarrhea in history. Infect Dis Clin North Am. 2004;18:261–274.
Francois Joseph Victor Broussais (1772–1838). System of physiological medicine. JAMA. 1969;209:1523.
Wilks S. Morbid appearances in the intestines of Miss Bankes. Lond Med Gaz. 1859;2:264–265
Crohn’s and Colitis Foundation of America. Diagnosing and managing IBD. 2011. www.ccfa.org/assets/pdfs/diagnosing-and-managing-ibd-1.pdf.
Bressler B, Marshall JK, Bernstein CN, et al. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: The Toronto Consensus. Gastroenterology. 2015;148(5):1035-1058.e3.
Svartz N. The treatment of 124 cases of ulcerative colitis with salazopyrine and attempts of desensibilization in cases of hypersensitiveness to sulfa. Acta Med Scand. 1948;131:465–472.
Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041–1048.
Bean RH. The treatment of chronic ulcerative colitis with 6-mercaptopurine. Med J Aust. 1962;49:592–593.
Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462–2476.
Wright AD. Ulcerative colitis complicated by polyarthritis treated by total colectomy. Proc R Soc Med. 1942;35:189–190.
Jostins L, Ripke S,Weersma RK, et al. International IBD Genetics Consortium (IIBDGC). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-124.
Shouval DS, Rufo PA. The Role of Environmental Factors in the Pathogenesis of Inflammatory Bowel Diseases: A Review. JAMA Pediatr. 2017;171:999-1005.
Ananthakrishnan AN, Khalili H, Konijeti GG, et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn’s disease. Gut. 2014;63:776-784.
Ananthakrishnan AN, Khalili H, Konijeti GG, et al. A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology. 2013;145:
Yu YR, Rodriguez JR. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Semin Pediatr Surg. 2017;26:349-355.
Davis SC, Robinson BL, Vess J, et al. Primary care management of ulcerative colitis. Nurse Pract. 2017 Dec 4. [Epub ahead of print]